These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9070210)
1. Mechanism involved in the antiplatelet activity of naloxone in human platelets. Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory mechanisms of naloxone on human platelets. Sheu JR; Lee YM; Lee LW; Luk HN; Yen MH Clin Exp Pharmacol Physiol; 1998; 25(7-8):585-91. PubMed ID: 9673433 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative. Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom. Huang TF; Sheu JR; Teng CM Thromb Haemost; 1991 Oct; 66(4):489-93. PubMed ID: 1665595 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets. Sheu JR; Kan YC; Hung WC; Ko WC; Yen MH Thromb Res; 1997 Nov; 88(3):259-70. PubMed ID: 9526946 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation. Lee YM; Lee JJ; Shen MY; Hsiao G; Sheu JR Eur J Pharmacol; 2006 May; 537(1-3):52-8. PubMed ID: 16624282 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets. Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558 [TBL] [Abstract][Full Text] [Related]
9. Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets. Sheu JR; Yeh GC; Fang CL; Lin CH; Hsiao G J Cardiovasc Pharmacol; 2002 Nov; 40(5):743-50. PubMed ID: 12409983 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase. Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in the antiplatelet activity of magnesium in human platelets. Sheu JR; Hsiao G; Shen MY; Fong TH; Chen YW; Lin CH; Chou DS Br J Haematol; 2002 Dec; 119(4):1033-41. PubMed ID: 12472585 [TBL] [Abstract][Full Text] [Related]
12. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction. Liu CZ; Huang TF Arch Biochem Biophys; 1997 Jan; 337(2):291-9. PubMed ID: 9016825 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. Sheu JR; Lee CR; Lin CH; Hsiao G; Ko WC; Chen YC; Yen MH Thromb Haemost; 2000 May; 83(5):777-84. PubMed ID: 10823277 [TBL] [Abstract][Full Text] [Related]
14. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C. Sheu JR; Kan YC; Hung WC; Su CH; Lin CH; Lee YM; Yen MH Thromb Res; 1998 Oct; 92(2):53-64. PubMed ID: 9792112 [TBL] [Abstract][Full Text] [Related]
15. C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis. Hsiao G; Chou PH; Shen MY; Chou DS; Lin CH; Sheu JR J Agric Food Chem; 2005 Oct; 53(20):7734-40. PubMed ID: 16190625 [TBL] [Abstract][Full Text] [Related]
16. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase. Liu FC; Liao CH; Chang YW; Liou JT; Day YJ Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675 [TBL] [Abstract][Full Text] [Related]
17. The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB(2) synthetase activity. Park WH; Kim KS; Kim KH; Kim DS; Kim CH Int Immunopharmacol; 2003 Jul; 3(7):971-8. PubMed ID: 12810354 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of antiplatelet and antithrombotic activity of midazolam in in vitro and in vivo studies. Hsiao G; Shen MY; Chou DS; Chang Y; Lee LW; Lin CH; Sheu JR Eur J Pharmacol; 2004 Mar; 487(1-3):159-66. PubMed ID: 15033388 [TBL] [Abstract][Full Text] [Related]
19. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets. Wang W; Wang YP; Sun WK; Xu YM; Xuan LJ Acta Pharmacol Sin; 2000 Sep; 21(9):859-63. PubMed ID: 11501172 [TBL] [Abstract][Full Text] [Related]
20. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity. Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]